Renal Medullary Carcinoma: Utility of [18F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management
{{output}}
The value of [18F]FDG PET/CT imaging in the management of SMARCB1-deficient renal medullary carcinoma (RMC), a rare and aggressive type of kidney cancer, has not been established. We sought to determine the utility of [18F]FDG PET/CT findings for the evaluatio... ...
